A case of primary cutaneous mucormycosis produced by the new species 1

12 A case of fungal necrotizing fasciitis that appeared after a car accident is described 13 in an immunocompetent Mexican woman. The patient did not respond to antifungal 14 treatment and died four days later. The fungus was molecularly identified as a new 15 species of Apophysomyces, namely Apophysomyces mexicanus. 16

[1]  G. Petrikkos,et al.  Cutaneous mucormycosis. , 2013, Skinmed.

[2]  D. Engelthaler,et al.  Whole Genome Sequence Typing to Investigate the Apophysomyces Outbreak following a Tornado in Joplin, Missouri, 2011 , 2012, PloS one.

[3]  J. Guarro,et al.  Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis. , 2012, The Journal of antimicrobial chemotherapy.

[4]  A. Bonifaz,et al.  Cutaneous zygomycosis. , 2012, Clinics in dermatology.

[5]  Russell E. Lewis,et al.  Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species , 2011, Clinical Microbiology Reviews.

[6]  J. Guarro,et al.  Apophysomyces variabilis Infections in Humans , 2011, Emerging infectious diseases.

[7]  J. Meis,et al.  Apophysomyces elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, and In Vitro Antifungal Susceptibility Pattern , 2010, Journal of Clinical Microbiology.

[8]  A. Chakrabarti.  Cutaneous zygomycosis : major concerns. , 2010, The Indian journal of medical research.

[9]  J. Guarro,et al.  Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. , 2010, Revista iberoamericana de micologia.

[10]  J. Ayala-Gaytán,et al.  Cutaneous zygomycosis in immunocompetent patients in Mexico. , 2010, Mycoses.

[11]  M. Cuenca‐Estrella,et al.  Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers , 2009, Antimicrobial Agents and Chemotherapy.

[12]  J. Meis,et al.  Changing epidemiology of an emerging infection: zygomycosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  A. Kumar,et al.  Fatal cellulitis caused by Apophysomyces elegans. , 2007, Indian journal of medical microbiology.

[14]  M. Brandt,et al.  Posaconazole Treatment for Apophysomyces elegans Rhino-Orbital Zygomycosis following Trauma for a Male with Well-Controlled Diabetes , 2007, Journal of Clinical Microbiology.

[15]  A. Chakrabarti,et al.  Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases , 2006, Modern Pathology.

[16]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  V. Sakhuja,et al.  Apophysomyces elegans: an Emerging Zygomycete in India , 2003, Journal of Clinical Microbiology.